124 results
8-K
EX-10.3
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
Executive's employment with the Company is terminated by the Company without Cause (and other than as a result of Executive's death or Permanent Disability … for Cause; Resignation Without Good Reason; Death or Permanent Disability.
(i) The Company may terminate Executive's employment with the Company
8-K
EX-10.2
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
) In the event Executive's employment with the Company is terminated by the Company without Cause (and other than as a result of Executive's death … in the applicable equity award documents.
6.3 Termination for Cause; Resignation Without Good Reason; Death or Permanent Disability.
(i) The Company may
8-K
EX-10.1
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
disability coverage, accidental death and dismemberment, a 401(k) plan, and a non-qualified deferred compensation plan (“Deferred Compensation Plan … ) days written notice.
This Agreement and the Executive’s employment hereunder will automatically terminate upon the Executive’s death, without any
8-K
EX-1.1
APTO
Aptose Biosciences Inc
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
family, (b) by will or intestate succession upon the death of the undersigned or (c) as a bona fide gift to a charity or educational institution … of the undersigned. This agreement and all authority herein conferred are irrevocable and shall survive the death or incapacity of the undersigned
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
therapeutic agent that inhibits expression of the MYC oncogene, leading to cell cycle arrest and programmed cell death (apoptosis) in human-derived
S-8
EX-4.1
2pgwft02j vyga6kx
21 Sep 23
Registration of securities for employees
5:10pm
8-K
EX-99.1
xfp84df8jme87
19 Jul 22
Financial Statements and Exhibits
5:53pm
8-K
EX-10.1
o2otjcm hhku9
28 Jun 22
Departure of Directors or Certain Officers
3:30pm
8-K
EX-99.1
wnyh3ib9zlfijr8uzc10
27 Jun 22
Financial Statements and Exhibits
9:55am
8-K
EX-99.1
xwnn4e1
2 May 22
Other Events
5:05pm
8-K
EX-10.1
r6q0s8d61l31ifwvch
11 Apr 22
Aptose Announces Executive Management Changes
5:04pm